Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban-Reference-Cited by-同舟云学术

Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban

Published:2021-09-12 Issue:12 Volume:19 Page:3008-3017
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Bosch Floris T. M.¹²^ORCID,Mulder Frits I.¹²^ORCID,Huisman Menno V.³,Zwicker Jeffrey I.⁴^ORCID,Di Nisio Marcello⁵^ORCID,Carrier Marc⁶,Segers Annelise⁷,Verhamme Peter⁸^ORCID,Middeldorp Saskia⁹^ORCID,Weitz Jeffrey I.¹⁰,Grosso Michael A.¹¹,Duggal Anil¹¹,Büller Harry R.²,Wang Tzu‐Fei⁶^ORCID,Garcia David¹²,Kamphuisen Pieter Willem¹²,Raskob Gary E.¹³,Es Nick²

Affiliation:

1. Department of Internal Medicine Tergooi Hospital Hilversum The Netherlands

2. Department of Vascular Medicine Amsterdam Cardiovascular Science Medical Centers Amsterdam UniversityUniversity of Amsterdam Amsterdam The Netherlands

3. Department of Medicine‐Thrombosis and Hemostasis Leiden University Medical Center Leiden the Netherlands

4. Division of Hemostasis and Thrombosis Division of Hematology and Oncology Beth Israel Deaconess Medical Center Harvard Medical School Boston USA

5. Department of Medicine and Ageing Sciences University G. D'Annunzio Chieti Italy

6. Department of Medicine Ottawa Hospital Research Institute at the University of Ottawa Ottawa ON Canada

7. ITREAS Academic Research Organization Amsterdam the Netherlands

8. Department of Vascular Medicine and Hemostasis University Hospitals Leuven Leuven Belgium

9. Department of Internal Medicine Radboud University Medical Center Nijmegen The Netherlands

10. McMaster University and the Thrombosis and Atherosclerosis Research Institute Hamilton ON Canada

11. Daiichi Sankyo Pharma Development Basking Ridge NJ USA

12. Division of Hematology Department of Medicine University of Washington Seattle WA USA

13. College of Public Health University of Oklahoma Health Sciences Center Oklahoma City OK USA

Funder

Daiichi Sankyo Company

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15516

Reference26 articles.

1. Venous thromboembolism in cancer patients: a population-based cohort study

2. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

3. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

4. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

5. Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic treatment in gastric cancer patients with overt bleeding: A propensity score matching analysis;World Journal of Clinical Oncology;2024-09-24

2. Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing;Clinical and Translational Oncology;2024-09-14

3. The timing of surgical interventions following the implantation of coronary drug-eluting stents in patients undergoing gastrointestinal cancer surgery: A multicenter retrospective cohort study;2024-02-06

4. Reducing bleeding risk in patients on oral anticoagulation therapy;Expert Review of Cardiovascular Therapy;2023-11-08

5. The phospholipase PNPLA7 functions as a positive indicator in human colorectal and gastric cancers;Medicine;2023-10-20